Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp312 | Osteoporosis: evaluation and imaging | ECTS2013

Correlation of bioelectrical impendance analysis and dual energy X-ray absorptiometry for bone mineral content and bone mineral density in young healthy humans

Cvetko Erna Davidovic , Nesic Nebojsa , Milas-Ahic Jasminka , Drenjancevic Ines

Introduction: Bioelectrical impendance analysis (BIA) and dual enargy X-ray absorptiometry (DXA) are two most common methods used for body composition analysis. The aim of this study was to investigate: i) if there is a correlation between body mineral content (BMC) determined by BIA and by DXA for bone mineral content (BMC) and ii) correlation of BMC (BIA) vs bone mineral density (BMD) of L1–L4 spine, dual femur total mean and neck mean.Methods: Tw...

ba0001pp324 | Osteoporosis: evaluation and imaging | ECTS2013

Strong diagnostic agreement between a novel ultrasound-based method for lumbar densitometry and dual-energy X-ray absorptiometry

Muratore Maurizio , Conversano Francesco , Casciaro Ernesto , Soloperto Giulia , Franchini Roberto , Greco Antonio , Quarta Eugenio , Casciaro Sergio

Introduction: Currently, osteoporosis is mainly diagnosed through dual-enargy X-ray absorptiometry (DXA). However, DXA cannot be used for early diagnoses through population mass screenings because of issues related to ionizing radiation employment. Aim of this study is to perform a preliminary clinical validation of a new ultrasound (US)-based method for vertebral densitometry.Methods: A total of 270 women were included in this study according to the fol...

ba0001pp368 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Portuguese and spanish FRAX® tool versions: a comparative analysis from EpiReumaPt

Gouveia Nelia , Canhao Helena , Rego Tania , Sousa Susana , Branco Jaime

EpiReumaPt is a cross-sectional, epidemiologic study to estimate the prevalence of rheumatic diseases in Portugal. Selected cases randomized from the 10 000 Portuguese subjects recruited are eventually observed by a rheumatologist. Portuguese and Spanish FRAX® tool were applied. The major osteoporotic (MOFR) and hip (HFR) fracture risk were calculated without DXA results.The FRAX tool has been developed by WHO to evaluate 10 years fracture risk. It ...

ba0001pp382 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

The relationship between cardiovascular risk and bone mineral density: an important role for anthropometry

de Jongh Renate , Jameson Karen , Syddall Holly , Sayer Avan , den Heijer Martin , Cooper Cyrus , Dennison Elaine

Introduction: Cardiovascular disease and osteoporosis have often been reported to coexist in older people. However, the literature is conflicting regarding size and indeed direction of the association. The aim of the present study was therefore to assess associations between the Framingham general cardiovascular risk score and bone characteristics in a cohort of older adults.Methods: We studied 374 men and 379 women, born 1931–1939, who participated...

ba0001pp411 | Osteoporosis: treatment | ECTS2013

Changes in low back pain and upper gastrointestinal symptoms in Japanese osteoporotic patients after switching to once-monthly oral minodronate from daily or weekly bisphosphonates

Okimoto Nobukazu , Sakai Akinori , Ikeda Satoshi , Yoshioka Toru , Teshima Kitau , Matsumoto Hidehiro , Tsurukami Hiroshi , Okazaki Yuichi , Nagashima Masato , Fukuda Fumio , Arita Shinobu

Introduction: Minodronate, a new-generation bisphosphonate (BP), is the first BP available as a once-monthly oral regimen in Japan. Aside from being a highly potent inhibitor of bone resorption, minodronate has been shown to possess antagonistic action against the P2X2/3 receptor, which has an important role in nociceptive transmission. The purpose of this study was to investigate the analgesic effects of once-monthly oral minodronate (MIN50 mg) on low back pain (LBP) associat...

ba0001pp413 | Osteoporosis: treatment | ECTS2013

Early response to once-monthly oral minodronate after switching from daily or weekly bisphosphonates in Japanese osteoporotic patients

Sakai Akinori , Ikeda Satoshi , Okimoto Nobukazu , Teshima Kitau , Arita Shinobu , Matsumoto Hidehiro , Tsurukami Hiroshi , Okazaki Yuichi , Nagashima Masato , Fukuda Fumio , Yoshioka Toru

Introduction: Minodronate, a highly potent, new-generation bisphosphonate (BP), is the first BP available as a once-monthly oral regimen in Japan. The aim of the present study was to investigate the effects of once-monthly oral minodronate on bone turnover markers (BTM) and bone mineral density (BMD) in osteoporotic patients previously using daily or weekly BPs in real clinical practice.Methods: We conducted a prospective multicenter study involving 11 i...

ba0001pp459 | Other diseases of bone and mineral metabolism | ECTS2013

Correlates of tissue mineral density of bone samples from total hip arthroplasty patients with type 2 diabetes: an ex vivo study

Pritchard Janet , Papaioannou Alexandra , Hurtig Mark , Giangregorio Lora , Atkinson Stephanie , Beattie Karen , Adachi J.D. , DeBeer Justin , Winemaker Mitchell , Avram Victoria , Schwarcz Henry

Introduction: Fracture risk is greater for adults with type 2 diabetes (T2D), despite normal or higher areal bone mineral density (aBMD) compared to controls. Tissue mineral density (TMD), measured by microCT, is more representative of actual mineral density than in vivo aBMD. The aim of this study was to determine whether TMD is greater in adults with T2D, and to investigate the correlates of TMD in adults with T2D.Methods: Using proximal femur...

ba0001pp475 | Other diseases of bone and mineral metabolism | ECTS2013

Multidisciplinary studies of ancient calcified tissues: renal stones from mummies

Capulli Mattia , Arrizza Lorenzo , Rucci Nadia , Piperni Sara Gemini , Quaresima Raimondo , Giuffra Valentina , Fornaciari Gino , Teti Anna , Ventura Luca

The renal stones found in the mummies of Pandolfo III Malatesta, Lord of Fano (1370–1427) and an anonymous nobleman from Popoli (XVIII century) were investigated using different techniques. Both specimens were examined with binocular stereomicroscopy (BSM) and scanning electron microscopy (SEM), also with energy dispersive X-ray analysis (EDX). Multiple tiny fragments from surface and inner portions were submitted to X-ray diffraction (XRD) analysis. Subsequently, the cal...

ba0001pp497 | Other diseases of bone and mineral metabolism | ECTS2013

A frameshift mutation in receptor activator of NF-κB reveals a potential ligand-independent mechanism for NF-κB activation

Dignan Cahal , Mellis David , Duthie Angela , Pangrazio Alessandra , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep , Crockett Julie

Osteoclast-poor autosomal recessive osteopetrosis is characterised by susceptibility to fracture despite high bone mineral density as a consequence of an absence of osteoclasts. One of the 12 receptor activator of NF-κB (RANK) mutations associated with this condition is a frameshift mutation encoding a protein that is truncated within the extracellular, N-terminal domain (R110Pfs). We investigated the effect of this mutation on osteoclast formation, receptor localisation ...

ba0002op7 | (1) | ICCBH2013

Bone mineralization density distribution, bone formation rate and bone turnover markers in a cohort of children with CKD before and after GH treatment

Fratzl-Zelman Nadja , Nawrot-Wawrzyniak Kamilla , Misof Barbara , Panczyk-Tomaszewska Malgorzata , Ziolkowska Helena , Roschger Paul , Klaushofer Klaus

Background and methods: A specific skeletal complication in children with CKD is growth impairment. The effects of recombinant human growth hormone (rhGH) therapy on bone turnover and bone material quality are not well understood. Bone matrix mineralization density distribution (BMDD) as assessed by quantitative backscattered electron microscopy (qBEI) is an important determinant of bone material quality and reflects bone turnover (average tissue age) and mineralization kineti...